Ning Tian

Title: **Ning Tian: Innovator in Pharmaceutical Injections**

Introduction

Ning Tian, a notable inventor based in Guangzhou, China, has made significant contributions to the field of pharmaceuticals. With a total of two patents to his name, Tian's innovations focus primarily on the development of specialized injections that utilize advanced solubilizing agents.

Latest Patents

Tian's latest patents include the formulation and preparation methods for 5α-androstane-3β,5,6β-triol injections. This particular injection employs hydroxypropyl-β-cyclodextrin as a solubilizing agent, ensuring optimal bioavailability of the active ingredients. The active component is formulated at a weight ratio of 1-20:40-500 to the hydroxypropyl-β-cyclodextrin. Additionally, his work describes a method that encompasses sequential dissolution of both the hydroxypropyl-β-cyclodextrin and the active compound in sterilized water, followed by processing steps such as decolorization, depyrogenation, filtration, and sterilization to yield the final injectable preparation. This patent also encapsulates a method for producing a solid for injection through the drying of the filtrate.

Career Highlights

Throughout his career, Ning Tian has worked with prominent pharmaceutical companies, including Guangzhou Cellprotek Pharmaceuticals Ltd. and Guangzhou Cellprotek Pharmaceutical Ltd. His experience in these organizations has been pivotal in advancing his research and innovation efforts.

Collaborations

Tian has collaborated with various professionals in the field, including coworkers Guangmei Yan and Jingxia Zhang. Their combined expertise has aided in the enhancement of Tian's research and the applicability of his patented inventions.

Conclusion

Ning Tian's innovative work stands out in the realm of pharmaceutical injections, significantly contributing to medical advancements through his patented methods. His collaborations and career achievements underline the significance of teamwork in fostering innovation within the industry.